APA

Chen-Liang T., Casado-Prieto A. M., Campos-Rodríguez V., Hurtado A. M., Amigo M. L., García-Malo M. D., Vicente V., Ortuño F. J. & Jerez A. (2018). An increased percentage of myeloid CD34+ bone marrow cells stratifies intermediate IPSS-R myelodysplastic syndrome patients into prognostically significant groups. : International journal of laboratory hematology.

Chicago

Chen-Liang T-H, Casado-Prieto A M, Campos-Rodríguez V, Hurtado A M, Amigo M L, García-Malo M D, Vicente V, Ortuño F J and Jerez A. 2018. An increased percentage of myeloid CD34+ bone marrow cells stratifies intermediate IPSS-R myelodysplastic syndrome patients into prognostically significant groups. : International journal of laboratory hematology.

Harvard

Chen-Liang T., Casado-Prieto A. M., Campos-Rodríguez V., Hurtado A. M., Amigo M. L., García-Malo M. D., Vicente V., Ortuño F. J. and Jerez A. (2018). An increased percentage of myeloid CD34+ bone marrow cells stratifies intermediate IPSS-R myelodysplastic syndrome patients into prognostically significant groups. : International journal of laboratory hematology.

MLA

Chen-Liang T-H, Casado-Prieto A M, Campos-Rodríguez V, Hurtado A M, Amigo M L, García-Malo M D, Vicente V, Ortuño F J and Jerez A. An increased percentage of myeloid CD34+ bone marrow cells stratifies intermediate IPSS-R myelodysplastic syndrome patients into prognostically significant groups. : International journal of laboratory hematology. 2018.